Kinematic and Kinetic Effects of Orthotic Devices for Subjects With Stage II Posterior Tibial Tendon Dysfunction
- Conditions
- Posterior Tibial Tendon Dysfunction
- Interventions
- Device: Arizona
- Registration Number
- NCT01749657
- Lead Sponsor
- State University of New York - Upstate Medical University
- Brief Summary
The lack of high quality evidence to guide conservative care for patients with posterior tibial tendon dysfunction (PTTD) has led to controversy over clinical care. Numerous orthotic devices are available to avoid a costly and debilitating surgery but no consensus on which to use has been made. The current study aims to link biomechanical testing of selected devices to clinical outcomes in subjects with PTTD after wearing a device for 12 weeks.
- Detailed Description
Orthotic devices serve as essential elements of conservative care programs for posterior tibial tendon dysfunction (PTTD). Data on currently used devices remain limited. Current device designs are restrictive and focus on correction of flatfoot kinematics in subjects with stage II PTTD. Restrictive designs that limit ankle motion may lead to weakness and altered gait dynamics. It remains unclear if less restrictive device designs would be more optimal for subjects with stage II PTTD. The aims of the current proposal are to examine the in-vivo biomechanics of different device designs and to use outcomes to identify the device and design optimal for subjects with stage II PTTD. Research Design: This study will use a laboratory based repeated measures design to explore the function of four different orthotic devices in a sample of 60 subjects with stage II PTTD at baseline. Then each subject will be followed prospectively for 12 weeks while wearing one of the orthotic devices. Clinical outcomes including strength, tendon morphology, and self-reported outcomes will be measured at 12 weeks. Baseline foot kinematics will be collected using a three segment foot model (first metatarsal, calcaneus, tibia) while data on ankle kinetics will be derived from the kinematic data and the ground reaction forces. Impact: There are currently no head-to-head comparisons available among the various devices used in the conservative management of stage II PTTD. The proposed study will provide the necessary controlled data to determine the kinematic and kinetic effects of selected devices and the specific components needed to optimize device design. Outcomes will be used to determine which designs are successful to use clinically.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 60
-
Inclusion Criteria Stage II PTTD
- Swelling
- Pain with Palpation along the tendon
- Rearfoot eversion
- Pain single leg heel raise
- Flexible flat foot deformity
- Able to walk 15 m
- > 40 years of age
- Unable to walk 15 m
- Symmes-Weinstein monofilament test 5.06 mm
- Inflammatory arthropathies (e.g. rheumatoid arthritis, psoriasis)
- Co-morbid foot conditions (e.g. hallux rigidis, plantar fasciitis)
- Inability to assume a STN posture
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Custom Extended Device and Shoe Arizona subjects will wear a custom extended foot plate orthotic device (Arizona Co) and Edge shoe (Aetrex Co) for 12 weeks. Custom Articulated device and Shoe Arizona subjects will wear a custom articulated device (Arizona Co) and Edge shoe (Aetrex Co)for 12 weeks Off-the-shelf Device and shoe Arizona subjects will wear an off-the-shelf orthotic device (AirLift PTTD Brace) and standard Edge shoe (Aetrex Co) for 12 weeks Custom Device - standard and Shoe Arizona subjects will wear a custom (standard) orthotic device (Arizona Co) and Edge shoes (Aetrex Co.) for 12 weeks.
- Primary Outcome Measures
Name Time Method Foot Function Index - Revised 12 weeks The Foot Function Index - Revised (FFI-R) is a newly published version of the original Foot Function Index (FFI) \[45\]. The original FFI is a validated, disease specific questionnaire that is widely used to measure foot function and document outcomes in observational studies of PTTD \[31, 33\]. Rasch analyses for the FFI-R indicated a Pearson reliability of 0.96 and item reliability of 0.93. The domains of the 34 items in the FFI-R questionnaire include pain and stiffness, social/emotional issues, personal disability, and social activity limitation. Although the FFI-R is relatively new, the 23 items from the FFI were the basis for the revised scale. The FFI has been used to measure outcomes for a variety of foot and ankle problems including plantar fasciitis, diabetes, and PTTD \[32\]. The overall score of the FFI-R will be used as a primary outcome variable while the subscales will be used as secondary outcome variables.
- Secondary Outcome Measures
Name Time Method Foot and Ankle Ability Measure 12 weeks Assess the self-reported functional outcomes of patients with primarily foot and ankle pain.
Ankle Strength 12 weeks Compare strength changes over the 12 week intervention. Strength measures will include isometric and isokinetic testing using a Biodex System 3 strength testing system
Hip Strength 12 weeks Compare strength changes over the 12 week intervention. Strength measures will include isometric and isokinetic testing using a Biodex System 3 strength testing system
Deep Posterior Compartment Strength 12 weeks Compare deep posterior compartment strength after 12 weeks across the 4 groups in the study
Trial Locations
- Locations (1)
Upstate Medical University
🇺🇸Syracuse, New York, United States